Velan Capital Investment Management’s Praxis Precision Medicines PRAX Stock Holding History

Velan Capital Investment Management’s Portfolio PRAX Stock Details PRAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$29.7M	Sell	88,781 -12,000	-12%	-$3.8M	18.1%	1
2026 Q1	$32.5M	Hold	100,781	–	–	20.34%	1
2025 Q4	$29.7M	Sell	100,781 -32,024	-24%	-$5.96M	17.23%	1
2025 Q3	$7.04M	Sell	132,805 -16,529	-11%	-$801K	6.61%	5
2025 Q2	$6.28M	Sell	149,334 -35,666	-19%	-$1.36M	6.2%	7
2025 Q1	$7.01M	Sell	185,000 -115,000	-38%	-$7.18M	7.21%	5
2024 Q4	$23.1M	Sell	300,000 -50,666	-14%	-$3.67M	19.92%	2
2024 Q3	$20.2M	Hold	350,666	–	–	18.87%	2
2024 Q2	$14.5M	Hold	350,666	–	–	8.31%	4
2024 Q1	$21.4M	Buy	350,666 +5,000	+1%	+$224K	9.72%	3
2023 Q4	$7.7M	Sell	345,666 -1	-0%	-$18	4.5%	7
2023 Q3	$8.87M	Hold	345,667	–	–	7.15%	2
2023 Q2	$5.96M	Hold	345,667	–	–	5.54%	5
2023 Q1	$4.19M	Buy	+345,667	New	+$14.6M	3.58%	10

Other funds holding PRAX

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Velan Capital Investment Management's PRAX Position: Q2 2026 in Review

Velan Capital Investment Management reduced its Praxis Precision Medicines (PRAX) stake by 12% in Q2 2026, selling an estimated $3.8M and leaving 88,781 shares worth $29.7M. The position accounts for 18.1% of the portfolio, ranked #1.

Velan Capital Investment Management first reported a position in PRAX in Q1 2023 and has held it in 14 quarters since. The position peaked at $32.5M in Q1 2026. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

Velan Capital Investment Management held 88,781 shares of Praxis Precision Medicines worth $29.7M as of Q2 2026.
Velan Capital Investment Management sold 12,000 Praxis Precision Medicines shares in Q2 2026, an estimated $3.8M.
Praxis Precision Medicines made up 18.1% of Velan Capital Investment Management's portfolio in Q2 2026, its #1 holding.
Velan Capital Investment Management first reported a position in Praxis Precision Medicines in Q1 2023 and has held it in 14 quarters since.
Velan Capital Investment Management's Praxis Precision Medicines position peaked at $32.5M in Q1 2026.
309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Velan Capital Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.